You have 9 free searches left this month | for more free features.

Abrocitinib

Showing 1 - 25 of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Learn About Abrocitinib in Adult Moderate to Severe Atopic

Not yet recruiting
  • Atopic Dermatitis
  • Eczema
  • Abrocitinib
  • (no location specified)
Jan 9, 2023

How Safe Abrocitinib is in Pregnant Women and Their Offspring

Not yet recruiting
  • Atopic Dermatitis
  • Abrocitinib
  • (no location specified)
Feb 8, 2023

Effects of Abrocitinib Treatment on Skin Barrier Function

Recruiting
  • Atopic Dermatitis
  • No Intervention
  • Kiel, Schleswig-Holstein, Germany
    UKSH, Campus Kiel
Dec 28, 2022

Severe Uncontrolled Atopic Dermatitis Trial (abrocitinib)

Available
  • Severe Uncontrolled Atopic Dermatitis
  • abrocitinib
  • (no location specified)
Jul 19, 2022

Atopic Dermatitis Trial in Canada, United States (Abrocitinib)

Recruiting
  • Atopic Dermatitis
  • Abrocitinib
  • Fountain Valley, California
  • +8 more
Jan 25, 2023

Atopic Dermatitis Trial in India (Abrocitinib 100 mg, Abrocitinib 200 mg)

Recruiting
  • Atopic Dermatitis
  • Abrocitinib 100 mg
  • Abrocitinib 200 mg
  • New Delhi, Delhi, India
  • +14 more
Jan 9, 2023

Medicine, Abrocitinib in People With Atopic Dermatitis

Recruiting
  • Dermatitis, Atopic
  • Abrocitinib
  • Seoul, Korea, Republic of
    Pfizer Tower
Jan 25, 2023

Healthy Volunteers Trial in New Haven (Abrocitinib tablet, Abrocitinib Suspension F1, Abrocitinib Suspension F2)

Completed
  • Healthy Volunteers
  • Abrocitinib tablet
  • +7 more
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Nov 2, 2021

Sarcoidosis Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Sarcoidosis
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Jan 24, 2023

Granuloma Annulare Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Granuloma Annulare
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Dec 19, 2022

Healthy Participants Trial in Hollywood (Abrocitinib, Omeprazole, Caffeine)

Completed
  • Healthy Participants
  • Abrocitinib
  • +3 more
  • Hollywood, Florida
    Research Centers of America ( Hollywood )
Mar 8, 2022

Food Allergy Trial in New York (Abrocitinib)

Recruiting
  • Food Allergy
  • Abrocitinib
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 29, 2022

Dermatitis, Atopic Trial in Germany

Recruiting
  • Dermatitis, Atopic
    • Bramsche, Germany
    • +7 more
    May 23, 2022

    Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)

    Recruiting
    • Toxic Epidermal Necrolysis
    • Abrocitinib
    • Fuzhou, Fujian, China
      Department of Dermatology, the First Affiliated Hospital of Fuji
    Oct 31, 2023

    Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • Abrocitinib 200 MG Oral Tablet
    • +2 more
    • (no location specified)
    Feb 21, 2023

    Molecular Signatures in Inflammatory Skin Disease

    Recruiting
    • Atopic Dermatitis
    • Psoriasis
    • Kiel, Germany
      Department of Dermatology, University Hospital Schleswig Holstei
    Jul 16, 2022

    Atopic Dermatitis Trial in Worldwide (abrocitinib)

    Available
    • Atopic Dermatitis
    • abrocitinib
    • Birmingham, Alabama
    • +50 more
    Jul 26, 2022

    Atopic Dermatitis Trial in Worldwide (Abrocitinib 200 mg, Dupilumab 300 mg)

    Completed
    • Atopic Dermatitis
    • Abrocitinib 200 mg
    • Dupilumab 300 mg
    • Birmingham, Alabama
    • +150 more
    Jun 9, 2022

    Atopic Dermatitis Trial

    Not yet recruiting
    • Atopic Dermatitis
      • (no location specified)
      Nov 16, 2023

      Learn About Study Medicine in People With Atopic Dermatitis.

      Recruiting
      • Atopic Dermatitis
      • Tokyo, Japan
        Pfizer Local Country Office
      Oct 24, 2022

      Traumatic Brain Injury Trial in Xi'an (Baricitinib 4 MG, Standard treatment)

      Not yet recruiting
      • Traumatic Brain Injury
      • Baricitinib 4 MG
      • Standard treatment
      • Xi'an, Shaanxi, China
        Tandu Hospital, Fourth Military Medical University
      Sep 26, 2023

      Atopic Dermatitis Trial in Netherlands

      Recruiting
      • Atopic Dermatitis
        • Leeuwarden, Friesland, Netherlands
        • +13 more
        May 18, 2022

        Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

        Not yet recruiting
        • Atopic Dermatitis
        • Baricitinib 4 MG
        • Azathioprine 1.5-2.5 mg/kg
        • Sari, Mazandaran, Iran, Islamic Republic of
          Iran
        Aug 1, 2023

        Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Placebo)

        Completed
        • Dermatitis
        • +9 more
        • PF-04965842 100 mg
        • +2 more
        • Birmingham, Alabama
        • +234 more
        Sep 17, 2021

        Renal Impairment Trial in Miami, Orlando, Brussels (PF-04965842)

        Completed
        • Renal Impairment
        • Miami, Florida
        • +3 more
        Mar 21, 2022